Speake, Cate
Greenbaum, Carla J.
Article History
First Online: 18 May 2023
Competing interests
: C.J.G. and C.S. participate in and receive funding as a clinical site for industry-sponsored or investigator-initiated trials of disease-modifying therapies. In the past 2 years, this has included ProventionBio, Sanofi, BMS, Janssen and Takeda. C.J.G. is a current member of, and previous Chair of, NIH-funded Diabetes TrialNet, which conducted the clinical trial that led to approval. C.S. is also a member of Diabetes TrialNet. C.J.G. is also a member of the NIH-sponsored Immune Tolerance Network, which conducts trials of disease-modifying therapies.